HomeAI · summaries
Storia in 3 fonti
Sun Pharma gets green signal on semaglutide in Brazil, its second export market
Sun Pharma gains ANVISA approval to launch semaglutide in Brazil, partnering with Hypera Pharma for diabetes treatment.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
swissinfo.ch
Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil approves Sandoz-marketed Owozy for type 2 diabetes, with launch planned in late 2026.
- ·
thehindubusinessline.com
Sun Pharma gets green signal on semaglutide in Brazil, its second export market
Sun Pharma gains ANVISA approval to launch semaglutide in Brazil, partnering with Hypera Pharma for diabetes treatment.
